QL9-35446-58487
3 vaccinations
5 coded responses
25 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 454 / OH
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Registered in v-safe
- 2021-04-08
- 2021-04-10
- 2021-04-17
- 2021-04-23
- 2021-05-01
- 2021-05-09
- 2021-05-14
- 2021-07-04
- 2021-10-02
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 21, dose 3MedDRA: Hypertension — Feeling: FairFree text: High blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — day 28, dose 3MedDRA: Hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: High blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2021-11-09
- 2021-11-12
- 2021-11-20
-
2022-01-07
Survey response — 3 months, dose 3MedDRA: Ageusia, Anosmia, Cough, Headache, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, headache, loss of smell and taste, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Survey response — 6 months, dose 3MedDRA: Diarrhoea, Nausea — Feeling: GoodFree text: Nausea and diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Survey response — 12 months, dose 3MedDRA: Fatigue, Headache, Rhinorrhoea, Vomiting — Feeling: GoodFree text: Runny nose, headache, exhaustion, vomitingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 21, dose 3
Symptoms: High blood pressure
Release 10 — day 28, dose 3
Symptoms: High blood pressure
Release 10 — 3 months, dose 3
Symptoms: Cough, headache, loss of smell and taste, runny nose
Release 11 — 6 months, dose 3
Symptoms: Nausea and diarrhea
Release 12 — 12 months, dose 3
Symptoms: Runny nose, headache, exhaustion, vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release